A REVIEW OF LINK ALTERNATIF MBL77

Not all individuals with CLL require therapy. Regardless of all the latest developments, the iwCLL nevertheless suggests watchful observation for sufferers with asymptomatic disorder.86 This suggestion relies on no less than two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (